Q1 2016 Holdings
Filed 2016-05-16 | 24 holdings | $123.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris therapeutics(ACRS) | Common | 00461U105 | $79.4M | 4,191,397 | 64.4% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $26.3M | 1,419,332 | 21.3% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $17.3M | 5,573,319 | 14.1% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $79.1K | 6,499,737 | 0.1% |
| Biotie Therapies Corp. | ADR | 09074D103 | $32.5K | 1,220,234 | 0.0% |
| Nabriva Therapeutics AG | ADR | 62957M104 | $28.2K | 3,151,700 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $26.8K | 1,599,592 | 0.0% |
| ProNAi Therapeutics, Inc. | Common | 74346L101 | $16.4K | 2,438,270 | 0.0% |
| Advanced Accelerator Applications S.A. | Common | 00790T100 | $16.0K | 455,798 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $12.5K | 2,019,955 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $10.7K | 990,449 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $9.9K | 1,200,000 | 0.0% |
| Capnia, Inc. | Common | 14066L105 | $8.9K | 7,466,352 | 0.0% |
| Kite Pharma, Inc. | Common | 49803L109 | $8.9K | 193,193 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $7.4K | 527,842 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | Common | 268158201 | $6.9K | 357,755 | 0.0% |
| MEI Pharma, Inc. | Common | 55279B202 | $3.5K | 2,767,718 | 0.0% |
| Carbylan Therapeutics | Common | 141384107 | $2.7K | 4,204,562 | 0.0% |
| ChemoCentryx, Inc.(CCXIEUR) | Common | 16383L106 | $2.2K | 887,906 | 0.0% |
| ReVance Therapeutics, Inc.(RVNCEUR) | Common | 761330109 | $1.9K | 77,373 | 0.0% |
| Ocera Therapeutics, Inc. | Common | 67552A108 | $451 | 153,331 | 0.0% |
| Zosano Pharma Corp | Common | 98979H103 | $227 | 98,515 | 0.0% |
| Capnia, Inc. | Warrant | 14066L113 | $215 | 932,910 | 0.0% |
| Palatin Technologies, Inc. | Common | 696077403 | $127 | 234,909 | 0.0% |